Industry Summits
Execs still mulling CVS-Caremark fallout
NEW YORK (Reuters) - Investors last week jeered U.S. drug store chain CVS Corp.'s move to buy pharmacy benefit manager Caremark Rx Inc. for nearly $21 billion. Full Article | Video
Pricing threat looms large for global drugmakers
NEW YORK (Reuters) - Finding new drugs is only half the battle. Getting governments and insurers to pay for them is a growing problem for manufacturers. Full Article | Video
New Merck drugs help push Vioxx off front page
NEW YORK (Reuters) - Merck & Co.'s recent launches of a new vaccine against cervical cancer and a promising diabetes drug could pay another major dividend: helping to take the focus off Vioxx, Merck's chief executive officer said. Full Article
Sign up here to be alerted via email about top news broken from these exclusive interviews, as well as the list of guests for upcoming Reuters Summits.
New Cardinal Health CEO faces tough choices
NEW YORK (Reuters) - Six months into his new job, Cardinal Health Inc.'s chief executive faces tough decisions on whether to cut losses at the company's troubled drug manufacturing unit and how to heal bruised relationships after a drastic consolidation of the customer service operation. Full Article
Generic drugmakers see potential in biotech
NEW YORK (Reuters) - Generic drugmakers expect to see progress soon on U.S. guidelines for marketing generic versions of costly biotechnology drugs as pressure increases from both governments and insurers to lower health-care costs. Full Article
US drug, device companies eye more FDA fees
NEW YORK (Reuters) - Makers of brand name drugs and devices sold in the United States are anticipating higher industry fees to take effect next year when lawmakers look to renew laws that help fund the Food and Drug Administration. Full Article
Cardinal mulls options on drug manufacturing unit
NEW YORK (Reuters) - Cardinal Health Inc. Chief Executive R. Kerry Clark said on Thursday he is evaluating whether to cut the company's ailing drug manufacturing business as part of his efforts to reshape the sprawling company. Full Article
Top quotes from the Health Summit
NEW YORK (Reuters) - The following are some of the top quotes from the 2006 Reuters Health Summit: Full Article
Bristol-Myers interim CEO keen to move on
NEW YORK (Reuters) - The interim chief executive of Bristol-Myers Squibb Co. said on Wednesday he has no interest in remaining in the position and is eager for the company to find a permanent CEO. Full Article
Merck CEO says any Vioxx settlements years away
NEW YORK (Reuters) - Merck & Co. Chief Executive Richard Clark said on Wednesday it could be several years before it considers settling thousands of lawsuits brought by people who claim to have been harmed by its withdrawn arthritis drug Vioxx. Full Article
More Health News
Speakers
What are Summits?
Reuters Summits are your direct link to top business leaders, investors and regulators. Our journalists interview heavyweights in a particular industry, spin out hard-hitting breaking news and sharp analysis that can often move markets. If you want to understand what the insiders are thinking, look for Reuters Summits. Launch Full Video
| Investment Outlook | Dec 8 - 11 | New York |
| Aerospace and Defense | Dec 15 - 17 | Washington, DC |
